“Bad Blood” is the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.įor his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism for beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. There was just one problem: the technology didn’t work. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares that valued the company at more than $9 billion, putting Holmes’ worth at an estimated $4.7 billion.

Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.In 2014, Theranos founder and CEO Elizabeth Holmes was widely viewed as the female Steve Jobs: a brilliant Stanford dropout whose startup promised to revolutionize the medical industry by making it easier and faster to test blood for diseases. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. There was just one problem: The technology didn't work.For years, Holmes had been misleading investors, FDA officials, and her own employees. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers.In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Bad Blood: Secrets and Lies in a Silicon Valley Startup Full

Bad blood john